Polysorbate 80

FDA Inactive Ingredient Details, DESCRIPTION

FDA Inactive Ingredient Details
DESCRIPTION

Suppliers

11 Listed Products, 1 Nanjing Bold Chemical, 3 Gangwal Chemicals, 1 BASF, 6 Seppic

REGULATORY FILINGS

3 Suppliers, 3 USDMF, 2 CEP/COS

SOLUTIONS BY APPLICATIONS

8 Solubilizers, 4 Parenteral, 2 Topical, 2 Surfactant & Foaming Agents, 2 Emulsifying Agents, 1 Thickeners and Stabilizers, 1 Co-Processed Excipients, 1 Film Formers & Plasticizers, 1 Direct Compression, 1 Rheology Modifiers, 1 API Stability Enhancers

FINISHED FORMULATIONS

829 ORAL, 482 TABLET, 149 INJECTABLE, 129 INJECTION, 84 TABLET, EXTENDED RELEASE, 68 SUSPENSION, 62 CAPSULE, 38 CAPSULE, DELAYED REL PELLETS, 33 TOPICAL, 28 OPHTHALMIC, 27 INTRAVENOUS, 25 SOLUTION, 23 NASAL, 23 SPRAY, METERED, 22 TABLET, DELAYED RELEASE, 19 POWDER, 19 SUSPENSION/DROPS, 17 GEL, 17 SOLUTION/DROPS, 16 CAPSULE, EXTENDED RELEASE, 16 CREAM, 16 ORAL-28, 16 VIAL, 14 CAPSULE, DELAYED RELEASE, 14 FOR SUSPENSION, 11 SUSPENSION, EXTENDED RELEASE, 10 INHALATION, 9 SUBCUTANEOUS, 9 VAGINAL, 8 INTRAMUSCULAR, 7 RECTAL, 6 FOR SUSPENSION, DELAYED RELEASE, 6 GRANULE, 6 ORAL-21, 6 OTIC, 6 SUPPOSITORY, 4 BUCCAL, 4 EMULSION, 4 GUM, CHEWING, 4 IV (INFUSION), 4 SYRINGE, 4 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE, 3 LOTION, 3 TABLET, ORALLY DISINTEGRATING, 2 CAPSULE, CAPSULE, DELAYED REL PELLETS, TABLET, 2 ENEMA, 2 FOR SOLUTION, 2 FOR SUSPENSION, EXTENDED RELEASE, 2 INTRAVITREAL, 2 POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER, 2 SINGLE-USE, 2 TABLET, CHEWABLE, 1 AEROSOL, FOAM, 1 AEROSOL, METERED, 1 CLOTH, 1 CONCENTRATE, 1 INJECTABLE, TABLET, 1 INTRA-ARTICULAR, 1 INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL, 1 INTRAMUSCULAR, ORAL, 1 INTRAVENOUS, SUBCUTANEOUS, 1 OINTMENT, 1 OPHTHALMIC, OTIC, 1 Oral, 1 PASTE, 1 SINGLE-DOSE, 1 SOLUTION, GEL FORMING/DROPS, 1 SUBCUTANEOUS LYOPHILIZED POWER, 1 SYRUP, 1 SYSTEM, 1 TROCHE/LOZENGE, 1 Tablet